Get App
Download App Scanner
Scan to Download
Advertisement

Ramco Cements Q3 Review: Dolat Capital Trims Earnings Estimates Amid Lower Profitability Outlook — Details Inside

The brokerage revises target price, valuing Ramco Cement at 11 times FY28E EV/Ebitda plus 50% of FY28E CWIP.

Ramco Cements Q3 Review: Dolat Capital Trims Earnings Estimates Amid Lower Profitability Outlook — Details Inside
Ramco Cements' Q3 results were below brokerage's estimates, however, volume came inline.
(Photo: Envato)
STOCKS IN THIS STORY
The Ramco Cements Ltd.
--

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Captial Report

The Ramco Cements Ltd. reported a weaker‑than‑expected Q3 FY26 performance, with results falling short of Dolat Capital's estimates, although volumes remained broadly in line with expectations.

Dolat Capital projects revenue/Ebitda/adjusted profit after tax compound annual growth rate of 8.8%/18.9%/116.6% over FY25–FY28E, driven by volume growth of 1.7%, 10.0% and 9.2% in FY26E/FY27E/FY28E, respectively. Realisation per tonne is expected to grow 5.0%/0.5%/0.0% over the same period.

The brokerage has sharply revised its estimates following lower‑than‑anticipated realisations. FY26E/FY27E/FY28E Ebitda estimates have been cut by 14.6%, 12.2% and 11.8%, respectively. Dolat Capital has also slashed its FY26E APAT estimate by 51.1%, factoring in lower‑than‑expected tax outgo on gains from land sales.

With profitability yet to show meaningful improvement, and after a 17% stock rally since the Q2 FY26 update, Dolat Capital maintained its ‘Sell' rating on Ramco Cement.

The brokerage has assigned a revised target price of Rs 874, valuing the company at 11 times FY28E EV/Ebitda plus 50% of FY28E CWIP.

Click on the attachment to read the full report:

Dolat Captial Ramco Cements Q3fy26 Results Review.pdf
VIEW DOCUMENT

ALSO READ:GSK Pharma Q3 Review: Motilal Oswal Lowers Target Price Despite Profit Beat — Here's Why

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search